CCCC vs. ASST
CCCC (C4 Therapeutics, Inc.) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. CCCC operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, CCCC returned 12.55%/yr vs -60.91%/yr for ASST. At a 0.12 correlation, their price movements are largely independent.
Performance
CCCC vs. ASST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CCCC achieves a 115.71% return, which is significantly higher than ASST's 0.34% return.
CCCC
- 1D
- -0.72%
- 1M
- 15.73%
- YTD
- 115.71%
- 6M
- 97.13%
- 1Y
- 190.14%
- 3Y*
- 12.55%
- 5Y*
- -35.79%
- 10Y*
- —
ASST
- 1D
- -0.27%
- 1M
- -18.67%
- YTD
- 0.34%
- 6M
- -14.47%
- 1Y
- -86.00%
- 3Y*
- -60.91%
- 5Y*
- —
- 10Y*
- —
CCCC vs. ASST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CCCC C4 Therapeutics, Inc. | 115.71% | -46.94% | -36.28% | -30.84% |
ASST Asset Entities Inc. Class B Common Stock | 0.34% | 50.46% | -84.65% | -89.13% |
Correlation
The correlation between CCCC and ASST is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023 | 0.12 |
The correlation between CCCC and ASST shifts across timeframes, from 0.10 (3 years) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CCCC:
$519.43M
ASST:
$912.74M
CCCC:
-$1.18
ASST:
-$25.54
CCCC:
12.65
ASST:
69.78
CCCC:
$28.71M
ASST:
$5.73M
CCCC:
$26.90M
ASST:
-$7.43M
CCCC:
-$107.31M
ASST:
-$304.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CCCC vs. ASST — Risk / Return Rank
CCCC
ASST
CCCC vs. ASST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for C4 Therapeutics, Inc. (CCCC) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CCCC | ASST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.43 | ||
| Sortino ratioReturn per unit of downside risk | +3.61 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 0.92 | +0.40 |
| Calmar ratioReturn relative to maximum drawdown | 3.67 | -0.90 | +4.57 |
| Martin ratioReturn relative to average drawdown | 7.13 | -1.08 | +8.21 |
Loading charts...
Drawdowns
CCCC vs. ASST - Drawdown Comparison
The maximum CCCC drawdown since its inception was -97.82%, roughly equal to the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for CCCC and ASST.
Loading charts...
Drawdown Indicators
| CCCC | ASST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.82% | -98.78% | +0.96% |
Max Drawdown (1Y)Largest decline over 1 year | -52.10% | -95.98% | +43.88% |
Max Drawdown (3Y)Largest decline over 3 years | -90.00% | -97.25% | +7.25% |
Max Drawdown (5Y)Largest decline over 5 years | -97.82% | — | — |
Current DrawdownCurrent decline from peak | -91.84% | -97.48% | +5.64% |
Average DrawdownAverage peak-to-trough decline | -72.01% | -90.44% | +18.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.79% | 79.36% | -52.57% |
Volatility
CCCC vs. ASST - Volatility Comparison
C4 Therapeutics, Inc. (CCCC) has a higher volatility of 27.58% compared to Asset Entities Inc. Class B Common Stock (ASST) at 24.00%. This indicates that CCCC's price experiences larger fluctuations and is considered to be riskier than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CCCC | ASST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.58% | 24.00% | +3.58% |
Volatility (6M)Calculated over the trailing 6-month period | 63.03% | 80.82% | -17.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 101.00% | 163.08% | -62.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 117.55% | 321.65% | -204.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 112.85% | 321.65% | -208.80% |
Dividends
CCCC vs. ASST - Dividend Comparison
Neither CCCC nor ASST has paid dividends to shareholders.
Financials
CCCC vs. ASST - Financials Comparison
This section allows you to compare key financial metrics between C4 Therapeutics, Inc. and Asset Entities Inc. Class B Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CCCC and ASST have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CCCC has higher volatility (27.58%) compared to ASST (24.00%). In terms of maximum drawdown, CCCC dropped -97.82% vs ASST's -98.78%.
CCCC currently has the higher Sharpe Ratio (1.90 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CCCC and ASST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer